^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BTX-9341

    i
    Other names: BTX-9341, BTX 9341, BTX9341
    Company:
    BioTheryX
    Drug class:
    CDK4/6 degrader
    over1year
    Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer (clinicaltrials.gov)
    P1, N=82, Recruiting, Biotheryx, Inc.
    New P1 trial • Metastases
    |
    fulvestrant • BTX-9341